Acadia Pharmaceuticals (ACAD)
Acadia Pharmaceuticals (ACAD - Get Report) is focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. This stock is trading up 8.8% to $2.47 in recent trading.
Today's Range: $2.40-$2.67
52-Week Range: $0.93-$3.06Volume: 5.02 million Three-Month Average Volume: 1.28 million From a technical perspective, ACAD is ripping higher here with monster upside volume. This move is quickly pushing ACAD within range of triggering a major breakout trade. That trade will hit once ACAD manages to take out some near-term overhead resistance levels at $2.64 to $2.80 with high volume. At last check, ACAD has hit an intraday high of $2.67 and volume is well above its three-month average action of 1.28 million shares. Traders should now look for long-biased trades in ACAD as long as it's trending above its 50-day at $2.27, and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.28 million shares. If that breakout triggers soon, then look for ACAD to re-test or possibly take out its next major overhead resistance levels at $3.06 to $3.30. To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts